TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
-6.78%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.35B
AUM Growth
+$2.35B
(-9.7%)
Cap. Flow
-$36.9M
Cap. Flow
% of AUM
-1.57%
Top 10 Holdings %
Top 10 Hldgs %
44.73%
Holding
156
New
14
Increased
27
Reduced
18
Closed
11
Top Buys
| 1 |
Biogen
BIIB
|
$15.7M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$12.3M |
| 3 |
Johnson & Johnson
JNJ
|
$12.2M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$10.6M |
| 5 |
CCP
Care Capital Properties, Inc.
CCP
|
$8.63M |
Top Sells
| 1 |
Alkermes
ALKS
|
$27.4M |
| 2 |
Agilent Technologies
A
|
$21.7M |
| 3 |
CPHD
Cepheid Inc
CPHD
|
$17.6M |
| 4 |
Eli Lilly
LLY
|
$16.2M |
| 5 |
UnitedHealth
UNH
|
$13.6M |
Sector Composition
| 1 | Healthcare | 90.58% |
| 2 | Real Estate | 3.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cencora
COR
$57.2B
| $25.9M | 1.1% |
330,687
| – | – |
|
27
Centene
CNC
$14.8B
| $22.6M | 0.96% |
800,000
+287,000
| +56% | +$8.11M |
|
28
Molina Healthcare
MOH
$9.6B
| $21.8M | 0.93% |
402,541
| – | – |
|
29
Thermo Fisher Scientific
TMO
$183B
| $19.9M | 0.85% |
141,120
+54,725
| +63% | +$7.72M |
|
30
Novartis
NVS
$248B
| $18.1M | 0.77% |
277,661
| – | – |
|
31
Universal Health Services
UHS
$11.6B
| $15.6M | 0.67% |
146,780
+12,100
| +9% | +$1.29M |
|
32
Idexx Laboratories
IDXX
$50.7B
| $15.5M | 0.66% |
132,352
| – | – |
|
33
iShares Biotechnology ETF
IBB
$5.68B
| $15.3M | 0.65% |
173,010
| – | – |
|
34
Neurocrine Biosciences
NBIX
$13.5B
| $15.2M | 0.65% |
391,869
-264,753
| -40% | -$10.2M |
|
|
ENDP
35
DELISTED
Endo International plc
ENDP
| $15.1M | 0.64% |
914,548
| – | – |
|
36
Omega Healthcare
OHI
$12.5B
| $14.3M | 0.61% |
458,616
+45,500
| +11% | +$1.42M |
|
37
HCA Healthcare
HCA
$95.4B
| $14.1M | 0.6% |
190,232
+94,548
| +99% | +$7M |
|
38
GSK
GSK
$79.3B
| $13.8M | 0.59% |
287,200
| – | – |
|
39
Sabra Healthcare REIT
SBRA
$4.56B
| $13.5M | 0.57% |
550,990
+94,800
| +21% | +$2.31M |
|
40
United Therapeutics
UTHR
$17.7B
| $13.4M | 0.57% |
93,100
| – | – |
|
41
Sarepta Therapeutics
SRPT
$1.98B
| $12.8M | 0.54% |
466,300
+252,200
| +118% | +$6.92M |
|
42
AstraZeneca
AZN
$255B
| $12.7M | 0.54% |
463,800
| – | – |
|
43
Medical Properties Trust
MPW
$2.66B
| $12.4M | 0.53% |
1,007,717
+168,500
| +20% | +$2.07M |
|
44
Sanofi
SNY
$122B
| $12.3M | 0.53% |
305,000
| – | – |
|
|
DHC
45
Diversified Healthcare Trust
DHC
$903M
| $12.2M | 0.52% |
646,554
+71,500
| +12% | +$1.35M |
|
|
WELL.PRI
46
DELISTED
Welltower Inc.
WELL.PRI
| $12M | 0.51% |
200,000
| – | – |
|
|
PRTK
47
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $11.7M | 0.5% |
762,581
| – | – |
|
48
Cigna
CI
$80.2B
| $11.5M | 0.49% |
86,400
| – | – |
|
49
Ventas
VTR
$30.7B
| $11M | 0.47% |
175,991
+23,500
| +15% | +$1.47M |
|
50
Cardinal Health
CAH
$36B
| $11M | 0.47% |
152,500
| – | – |
|